BI-PEGLYTE
BI-PEGLYTE
Approved
DIN Number
02326302
Drug Class
Human
Market Date
Jun 6, 2010
Company
HC
pendopharm division of pharmascience inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02326302
AIG Number0652579001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
A06AB52 BISACODYL, COMBINATIONS
Product Specifications
Dosage FormTablet (Delayed-Release)
,
Powder For Solution
,
Kit
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification
ACTIVE INGREDIENTS (6)
BISACODYLActive
Strength: 5 MG / TAB
Monograph: BISACODYL
POLYETHYLENE GLYCOL 3350Active
Strength: 59.55 G / SACHET
Monograph: POLYETHYLENE GLYCOL 3350
POTASSIUM CHLORIDEActive
Strength: 0.76 G / SACHET
Monograph: POTASSIUM CHLORIDE
SODIUM BICARBONATEActive
Strength: 1.69 G / SACHET
Monograph: SODIUM BICARBONATE
SODIUM CHLORIDEActive
Strength: 1.46 G / SACHET
Monograph: SODIUM CHLORIDE
SODIUM SULFATEActive
Strength: 5.74 G / SACHET
Monograph: SODIUM SULFATE